Deepak Chitkara
Pilani, RJ 333031, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Rapamycin loaded lipid-polymer hybrid nanoparticles in a topical hydrogel for the treatment of psoriasis.
Journal: Journal of pharmaceutical sciences
Published: November 04, 2025
Lipopolymeric Nanoplex-Mediated CRISPR/Cas9 Delivery for VEGF-A Knockdown in Psoriatic Angiogenesis.
Lipopolymeric Nanoplex-Mediated CRISPR/Cas9 Delivery for VEGF-A Knockdown in Psoriatic Angiogenesis.
Journal: ACS applied bio materials
Published: October 31, 2025
cRGD-Functionalized Nanohybrid Conjugates Codelivering Temozolomide and Rapamycin for Treating Glioblastoma Multiforme: In Vitro and In Vivo Evaluation.
Journal: Molecular pharmaceutics
Published: October 23, 2025
Lipid-polymer hybrid nanoplex loaded microneedle patches as a corneal delivery platform for CRISPR/Cas expressing plasmid.
Journal: International journal of biological macromolecules
Published: September 28, 2025
QbD Optimized Nanoemulsion Based Topical Formulation of Jatyadi Taila: Unveiling its In Vitro and In Vivo Efficacy for Enhanced Wound Healing.
Journal: Pharmaceutical research
Published: April 24, 2025
Autophagy as a potential therapeutic target in regulating improper cellular proliferation.
Journal: Frontiers in pharmacology
Published: February 18, 2025
Can breakthroughs in dermal and transdermal macromolecule delivery surmount existing barriers and revolutionize future therapeutics?
Journal: Journal of translational medicine
Published: September 07, 2024
Neurotensin Conjugated Polymeric Porous Microparticles Suppress Inflammation and Improve Angiogenesis Aiding in Diabetic Wound Healing.
Journal: Macromolecular bioscience
Published: August 19, 2024
Eugenol-Loaded Lipid Nanoparticles-Derived Hydrogels Ameliorate Psoriasis-like Skin Lesions by Lowering Oxidative Stress and Modulating Inflammation.
Journal: ACS pharmacology & translational science
Published: August 15, 2024
Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects.
Journal: RSC advances
Published: July 04, 2024
Downregulation of microRNA-29b in cancer and fibrosis: molecular insights and clinical implications.
Downregulation of microRNA-29b in cancer and fibrosis: molecular insights and clinical implications.
Journal: Drug discovery today
Published: May 18, 2024
Last Updated: 09/26/2026